How should a patient with chronic liver disease be managed during an inpatient hospitalization?

Management of Chronic Liver Disease Patient in IPD Ward

All hospitalized patients with chronic liver disease should receive immediate diagnostic paracentesis upon admission if they have ascites, along with systematic infection prevention measures and careful monitoring for acute-on-chronic liver failure (ACLF).

Initial Assessment and Diagnostic Workup

Perform diagnostic paracentesis immediately for any patient with ascites or symptoms of encephalopathy 1. Testing must include:

• Serum ascites albumin gradient (SAAG)
• Cell count with differential
• Gram stain and culture

This cannot be delayed—early diagnosis of spontaneous bacterial peritonitis (SBP) directly impacts mortality.

Infection Prevention Protocol (Critical for Mortality Reduction)

Implement these measures immediately upon admission 2:

• Stop proton pump inhibitors unless there is a clear, current indication (reduces infection risk)
• Remove Foley catheters as soon as possible—use only when absolutely necessary to prevent nosocomial UTIs
• Avoid anticholinergic medications in patients >65 years (causes urinary retention)
• Continue SBP prophylaxis if already prescribed for secondary prevention
• Minimize sedating medications:
  • No benzodiazepines (including zolpidem)
  • Avoid opiates (including tramadol)
  • These increase aspiration risk and worsen hepatic encephalopathy

Ascites and Volume Management

For patients with tense ascites, perform therapeutic paracentesis for symptom relief and aspiration prevention 2, 1.

Albumin replacement protocol 1:

• When removing >5 L: Give 20-25% IV albumin at 6-8 g per liter removed
• For smaller volumes: Consider albumin if patient has hypotension, renal insufficiency, or electrolyte abnormalities

Diuretic management 1:

• Use dietary sodium restriction plus diuretics at lowest effective dose
• For volume overload: Escalate to IV loop diuretics (furosemide or bumetanide) given 2-3 times daily or as continuous infusion
• Monitor daily weights, urine output, electrolytes, and renal function
• Escalate cautiously every 2-3 days based on response

Hyponatremia Management

For severe or symptomatic hyponatremia 1:

• Sodium AND water restriction (limit fluids to 1-1.5 L daily)
• Modify or discontinue diuretics and laxatives
• Add IV albumin based on volume assessment
• Consider oral vasoconstrictor therapy

For refractory cases, involve transplant team and consider IV vasoconstrictors, hypertonic saline, vaptans, or renal replacement therapy 1.

Infection Surveillance and Management

Monitor closely for infections—they are the leading cause of ACLF and death 2:

• Fungal infections occur in 2-16% of ACLF patients and are almost always nosocomial
• Risk factors: Antibiotic use, high MELD score, AKI, diabetes, prolonged hospitalization, ICU admission
• If suspected infection not responding to antibiotics after 48 hours: Consider MDR organisms or fungal infection
• First antibiotic dose should be given in the emergency room—each hour delay increases mortality 2

Antibiotic selection must account for 2:

1. Where infection was acquired (community vs nosocomial)
2. Severity of infection
3. Local resistance patterns
4. Recent antibiotic exposure

De-escalate antibiotics once cultures return to reduce MDR colonization risk.

Hepatic Hydrothorax

For patients with dyspnea/hypoxemia: Perform therapeutic thoracentesis immediately for symptom relief and lung expansion 1.

Vaccination Status

Ensure vaccines are current 2:

• COVID-19, HAV/HBV, annual influenza
• Pneumococcus every 5 years (age >65, but consider for all cirrhosis patients)
• Herpes zoster (2 doses, 2-6 months apart, age >50)
• Tdap every 10 years

Critical Pitfalls to Avoid

• Do not rely on INR for bleeding risk assessment in critically ill cirrhosis patients—it does not reflect the rebalanced coagulation state 2
• Do not overuse lactulose—causes vomiting and dehydration, increasing aspiration risk 2
• Minimize hospital length of stay—longer stays increase nosocomial infection risk 2
• Monitor airway carefully in patients with GI bleeding and/or hepatic encephalopathy 2

Refractory Cases

Refer for TIPS evaluation when patients have refractory ascites, hydrothorax, volume overload, or hyponatremia 1. Involve the transplant team early for multidisciplinary management.